Article info

Download PDFPDF
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect
  1. Correspondence to Dr Carmen Tur, Multiple Sclerosis Centre of Catalonia (Cemcat), Neurology-Neuroimmunology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain; ctur{at}cem-cat.org
View Full Text

Citation

Tur C
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect

Publication history

  • Received August 15, 2013
  • Revised August 18, 2013
  • Accepted August 20, 2013
  • First published September 17, 2013.
Online issue publication 
July 09, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.